Literature DB >> 10750463

Determinants of hospital admission among HIV-positive people in British Columbia.

A E Weber1, B Yip, M V O'Shaughnessy, J S Montaner, R S Hogg.   

Abstract

BACKGROUND: This study was initiated to evaluate the demographic and clinical determinants of admission to hospital among HIV-positive men and women receiving antiretroviral therapy in British Columbia.
METHODS: The analysis was restricted to participants enrolled in the HIV/AIDS Drug Treatment Program between September 1992 and March 1997 who had completed an annual participant survey, had a viral load determination and had signed a consent form allowing electronic access to their inpatient hospital records. A record linkage was conducted with the BC Ministry of Health to obtain all records of hospital admissions from April 1991 to March 1997. Statistical analyses were carried out using parametric and nonparametric methods and multivariate logistic analyses.
RESULTS: The study sample comprised 947 participants (859 men, 88 women). Of these, 165 (17%) were admitted to hospital during the study period from May 1, 1996, to Mar. 31, 1997. The median number of admissions was 1 (interquartile range [IQR] 1-2 admissions), and the median length of stay per admission was 3 days (IQR 1-8 days). Admission to hospital was associated with being unemployed (82% of those admitted v. 58% of those not admitted), being an injection drug user (24% v. 17%), reporting a fair or poor health status (46% v. 29%) and having a physician experienced in the management of HIV/AIDS (31% v. 24%). Examination of clinical determinants demonstrated that hospital admission was associated with a previous admission (72% v. 46%), a high viral load (median 74,000 v. 14,000 HIV-1 RNA copies/mL), a low CD4 count (median 0.16 v. 0.27 x 10(9)/L) and an AIDS diagnosis (44% v. 24%). Multivariate logistic regression analysis revealed that being admitted to hospital was independently associated with being unemployed (odds ratio [OR] 2.64, 95% confidence interval [CI] 1.66-4.20), having been previously admitted to hospital (OR 2.30, 95% CI 1.53-3.46), having a high viral load at baseline (OR 1.45, 95% CI 1.16-1.80), being an injection drug user (OR 1.63, 95% CI 1.02-2.62) and having an experienced physician (OR 1.98, 95% CI 1.29-3.03).
INTERPRETATION: Hospital admission among participants in this study was found to be associated with marginalization and poor health status.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750463      PMCID: PMC1231269     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  20 in total

1.  International epidemiology of HIV and AIDS among injecting drug users.

Authors:  D C Des Jarlais; S R Friedman; K Choopanya; S Vanichseni; T P Ward
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

Review 2.  HIV viral load markers in clinical practice.

Authors:  M S Saag; M Holodniy; D R Kuritzkes; W A O'Brien; R Coombs; M E Poscher; D M Jacobsen; G M Shaw; D D Richman; P A Volberding
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

3.  Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival.

Authors:  M M Kitahata; T D Koepsell; R A Deyo; C L Maxwell; W T Dodge; E H Wagner
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 91.245

4.  AIDS. Virological mayhem.

Authors:  S Wain-Hobson
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

5.  Resource utilization and stage of illness: a study of an outpatient AIDS clinic.

Authors:  A Bavry; P D Mauldin
Journal:  AIDS Patient Care STDS       Date:  1996-10       Impact factor: 5.078

6.  The influence of health-related quality of life and social characteristics on hospital use by patients with AIDS in the Boston Health Study.

Authors:  J S Weissman; P D Cleary; G R Seage; C Gatsonis; J S Haas; S Chasan-Taber; A M Epstein
Journal:  Med Care       Date:  1996-10       Impact factor: 2.983

7.  Mortality among drug users in the AIDS era.

Authors:  J J Goedert; G Pizza; F M Gritti; P Costigliola; A Boschini; A Bini; C Lazzari; A Palareti
Journal:  Int J Epidemiol       Date:  1995-12       Impact factor: 7.196

8.  High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.

Authors:  M Piatak; M S Saag; L C Yang; S J Clark; J C Kappes; K C Luk; B H Hahn; G M Shaw; J D Lifson
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Survival with AIDS in Massachusetts, 1979 to 1989.

Authors:  G R Seage; S Oddleifson; E Carr; B Shea; L Makarewicz-Robert; M van Beuzekom; A De Maria
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

10.  Patterns of hospital use by patients with diagnoses related to HIV infection.

Authors:  L J Kozak; E McCarthy; M Moien
Journal:  Public Health Rep       Date:  1993 Sep-Oct       Impact factor: 2.792

View more
  8 in total

1.  Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially Preventable.

Authors:  Ank E Nijhawan; Ellen Kitchell; Sarah Shelby Etherton; Piper Duarte; Ethan A Halm; Mamta K Jain
Journal:  AIDS Patient Care STDS       Date:  2015-07-08       Impact factor: 5.078

2.  Predictors of hospitalization for HIV-positive women and men drug users, 1996-2000.

Authors:  Ellie E Schoenbaum; Yungtai Lo; Michelle Floris-Moore
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

3.  Predictors of early hospital readmission in HIV-infected patients with pneumonia.

Authors:  Anita Palepu; Huiying Sun; Laura Kuyper; Martin T Schechter; Michael V O'Shaughnessy; Aslam H Anis
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128

4.  Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?

Authors:  Nancy F Crum-Cianflone; Greg Grandits; Sara Echols; Anuradha Ganesan; Michael Landrum; Amy Weintrob; Robert Barthel; Brian Agan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

5.  Hospital utilization and costs in a cohort of injection drug users.

Authors:  A Palepu; M W Tyndall; H Leon; J Muller; M V O'Shaughnessy; M T Schechter; A H Anis
Journal:  CMAJ       Date:  2001-08-21       Impact factor: 8.262

6.  The cost of inaction on HIV transmission among injection drug users and the potential for effective interventions.

Authors:  Laura M Kuyper; Robert S Hogg; Julio S G Montaner; Martin T Schechter; Evan Wood
Journal:  J Urban Health       Date:  2004-12       Impact factor: 3.671

7.  Modelling clinical progression and health care utilization of HIV-positive patients in British Columbia prior to death.

Authors:  Z Cui; E Grafstein; B Yip; R Hogg; J S G Montaner; V D Lima
Journal:  HIV Med       Date:  2014-03-18       Impact factor: 3.180

8.  Hospitalizations and its related factors in HIV/AIDS patients in Tehran, Iran.

Authors:  Mahboobeh Hajiabdolbaghi; Sirous Jafari; Sedighe Mansouri; Mojtaba Hedayat Yaghoobi
Journal:  Med J Islam Repub Iran       Date:  2014-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.